Salma Nozhat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Salma Nozhat has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Arzhangzadeh
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
1 shared publication - Mahmood Zamirian
Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
1 shared publication - Roozbeh Narimani Javid
Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute Tehran University of Medical Sciences Tehran Iran
1 shared publication Sarvenaz Salahi
Minimally Invasive Surgery Research Center Iran University of Medical Science Tehran Iran
1 shared publicationSasan Shafei
Skull Base Research Center, Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication- Soorena Khorshidi
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
1 shared publication
Latest Publications
- Open Access
- 25 June 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e8908
Clinical case of Cor triatriatum sinister, a dilemma of anticoagulation: A case report and literature review
Key Clinical Message: Cor triatriatum is a rare congenital heart abnormality in which a membrane separates the left atrium (LA; sinister) or the right atrium (dexter) into two compartments. It is also a long‐forgotten cause of atrial fibrillation (AF) and substantially higher rates of blood stagnation, particularly proximal to the additional septum in the LA. In this case report, we faced a CHA2DS2‐VASc score of 1 in patients with non‐valvular AF due to Cor triatriatum sinister (CTS). The decision to start anticoagulants in this particular case was controversial, so we reviewed the literature to assess and address it. We present our case and discuss the indication of anticoagulants in this unique clinical scenario, accompanied by a literature review. Facing this dilemma of starting anticoagulants in special cases of CTS and AF should be individualized and need more investigation. However, till this moment, based on similar reports, it seems to be rational to consider CTS Per se as an additional risk stratification marker beyond the CHA2DS2‐VASc score start anticoagulant until the surgical resection. Considering CTS as the sole indication of anticoagulant in patients with normal sinus rhythm is a complex matter that needs further investigation.
- 25 June 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (7) , e8908
Open AccessClinical case of Cor triatriatum sinister, a dilemma of anticoagulation: A case report and literature review
Key Clinical Message: Cor triatriatum is a rare congenital heart abnormality in which a membrane separates the left atrium (LA; sinister) or the right atrium (dexter) into two compartments. It is also a long‐forgotten cause of atrial fibrillation (AF) and substantially higher rates of blood stagnation, particularly proximal to the additional septum in the LA. In this case report, we faced a CHA2DS2‐VASc score of 1 in patients with non‐valvular AF due to Cor triatriatum sinister (CTS). The decision to start anticoagulants in this particular case was controversial, so we reviewed the literature to assess and address it. We present our case and discuss the indication of anticoagulants in this unique clinical scenario, accompanied by a literature review. Facing this dilemma of starting anticoagulants in special cases of CTS and AF should be individualized and need more investigation. However, till this moment, based on similar reports, it seems to be rational to consider CTS Per se as an additional risk stratification marker beyond the CHA2DS2‐VASc score start anticoagulant until the surgical resection. Considering CTS as the sole indication of anticoagulant in patients with normal sinus rhythm is a complex matter that needs further investigation.